Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.
about
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@ast
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@en
type
label
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@ast
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@en
prefLabel
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@ast
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@en
P2093
P2860
P1433
P1476
Safety and efficacy of romiplo ...... imary immune thrombocytopenia.
@en
P2093
Beng H Chong
Drew Provan
Francesco Rodeghiero
Jaime Garcia-Chavez
Jeffrey Wasser
Melissa Eisen
Michael Steurer
Nancy Carpenter
Roger Lyons
Xuena Wang
P2860
P304
P356
10.3324/HAEMATOL.2016.161968
P577
2017-04-14T00:00:00Z